Search research articles
Contact Us
Filters
Showing results (121-130 of 703) with videos related to
Page
of 71
Sort By:
Annals of Clinical and Translational Neurology
|
January 12, 2026
Effects of Biological Sex and Age on Cerebrospinal Fluid Markers-A Retrospective Observational Study
Isabel-Sophie Hafer, Simon Faissner, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 9, 2018
Dietary fatty acids and susceptibility to multiple sclerosis
Stefanie Haase, Aiden Haghikia, Ralf Gold, et al.
Therapeutic Advances in Neurological Disorders
|
April 3, 2026
A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis
Krzysztof Selmaj, Ralf Gold, Igor Selmaj, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
August 6, 2015
Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy
Antonios Kerasnoudis, Kalliopi Pitarokoili, Ralf Gold, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
January 16, 2013
Correlation between frequency of microembolic signals and efficacy of antiplatelet therapy in symptomatic carotid disease
Antonios Kerasnoudis, Saskia H Meves, Ralf Gold, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 4, 2013
Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models
Fred Lühder, Ralf Gold, Alexander Flügel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 13, 2016
Tocilizumab, MS, and NMOSD
Ingo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
Expert Review of Neurotherapeutics
|
August 16, 2013
The fumaric acid ester BG-12: a new option in MS therapy
De-Hyung Lee, Martin Stangel, Ralf Gold, et al.
Nature Reviews. Drug Discovery
|
August 11, 2019
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Simon Faissner, Jason R Plemel, Ralf Gold, et al.
Neuropsychologia
|
February 5, 2008
Response inhibition in Huntington's disease-a study using ERPs and sLORETA
Christian Beste, Carsten Saft, Jürgen Andrich, et al.
Page
of 71
Search research articles
Search
Showing results (121-130 of 703) with videos related to
Sort By:
Page
of 71
Annals of Clinical and Translational Neurology
|
January 12, 2026
Effects of Biological Sex and Age on Cerebrospinal Fluid Markers-A Retrospective Observational Study
Isabel-Sophie Hafer, Simon Faissner, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 9, 2018
Dietary fatty acids and susceptibility to multiple sclerosis
Stefanie Haase, Aiden Haghikia, Ralf Gold, et al.
Therapeutic Advances in Neurological Disorders
|
April 3, 2026
A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis
Krzysztof Selmaj, Ralf Gold, Igor Selmaj, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
August 6, 2015
Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy
Antonios Kerasnoudis, Kalliopi Pitarokoili, Ralf Gold, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
January 16, 2013
Correlation between frequency of microembolic signals and efficacy of antiplatelet therapy in symptomatic carotid disease
Antonios Kerasnoudis, Saskia H Meves, Ralf Gold, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
January 4, 2013
Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models
Fred Lühder, Ralf Gold, Alexander Flügel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 13, 2016
Tocilizumab, MS, and NMOSD
Ingo Kleiter, Ilya Ayzenberg, Manabu Araki, et al.
Expert Review of Neurotherapeutics
|
August 16, 2013
The fumaric acid ester BG-12: a new option in MS therapy
De-Hyung Lee, Martin Stangel, Ralf Gold, et al.
Nature Reviews. Drug Discovery
|
August 11, 2019
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Simon Faissner, Jason R Plemel, Ralf Gold, et al.
Neuropsychologia
|
February 5, 2008
Response inhibition in Huntington's disease-a study using ERPs and sLORETA
Christian Beste, Carsten Saft, Jürgen Andrich, et al.
Page
of 71